Collaborating Student, MCPHS University
Academic & Professional Experience
Research Assistant, Mass General Brigham and Harvard Medical School (2026)
Regulatory Affairs Team Member, Industry Pharmacists Organization (IPhO) (2025-Present)
Student Researcher, Center for Research and Development, MCPHS University (2025)
Pharmacy Intern, Department of Pharmacy, Tufts Medical Center (2025)
Chapter President, Korean-American Science & Engineering Association (KSEA) (2024-Present)
Research Intern, Salpida Co., Ltd. (2023)
Education
Pharm.D. Candidate, MCPHS University, Boston, 2027
M.S. Candidate in Regulatory Affairs and Health Policy, MCPHS University, Boston, 2027
B.Sc. in Pharmaceutical Sciences, MCPHS University, Boston, 2025
Yoonseok is currently pursuing a Doctor of Pharmacy and a Master of Science in Regulatory Affairs at MCPHS University. He has primarily worked on analyzing healthcare datasets to enhance pharmaceutical regulatory strategies and operational efficiency. His focus was on developing an AI-driven framework to optimize Pharmacy Benefit Manager (PBM) transparency, where he evaluated structured data tools to reduce delays in drug access decisions. He also led a project to assess 503B outsourcing risks, integrating FDA cGMP requirements with real-world operational insights to evaluate hospital procurement strategies. In his earlier research, he utilized real-world patient data (RWD) from oncology populations to identify unmet medical needs and inform evidence-based product positioning. At the NOVA Lab, he is actively contributing to in vivo studies evaluating the tissue biodistribution/pharmacokinetics of NIR fluorophores and polymeric nanoparticles.
Collaborating Student, MCPHS University
Education
Pharm.D. Candidate, MCPHS University, Boston, 2031
HyeonRyeong Cha is a Pre-Professional Year 1 (PP1) as a Pharm.D. candidate in MCPHS university. She has a strong interest in pharmaceutical sciences, with a focus on drug formulation, advanced delivery systems, and their translational applications. She is currently collaborating with the NOVA Lab on a scholarly review project exploring innovative strategies in drug development and nanomedicine.